Explore how AI is revolutionizing neurodegenerative drug development across discovery, preclinical, and clinical research.
Read More
Discover how a complex first-in-human gene therapy trial for a rare neuromuscular disease overcame regulatory, logistical, and vendor challenges with precision project management and deep therapeutic expertise.
Explore challenges, patient-centric trial design, & how expert CROs accelerate groundbreaking therapies for gene therapy in rare diseases.
Explore how precision medicine is revolutionizing rare disease treatment through targeted therapies, gene editing, and AI-driven solutions.
Learn about the unique challenges in clinical trials, regulatory hurdles, and the role of collaboration in gene therapy for rare diseases.
Discover the top 10 CROs in 2025. Learn about industry leaders in clinical trials, technology adoption, & global healthcare solutions.
Explore how TFS HealthScience navigated the complexities of DMD gene therapy studies, ensuring successful site selection and patient recruitment.
Explore the purpose, process, and characteristics of the four phases of clinical research, crucial for validating drug safety and efficacy.
Discover the latest insights and future prospects in Epidermolysis Bullosa (EB) treatment, including gene therapy and regenerative approaches.
Discover the importance of patient-centricity in pediatric rare disease studies. TFS experts Scott Schliebner and Alison Sampson share insights and strategies for improving clinical trials, including patient engagement and decentralized trials.